Navigation Links
BioMed Realty Trust to Report 2010 Third Quarter Results
Date:10/18/2010

SAN DIEGO, Oct. 18 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2010 after the market closes on Wednesday, November 3, 2010.

Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 9:00 a.m. Pacific Time on Thursday, November 4, 2010 to discuss the company's financial results and operations for the quarter.

The call will be open to all interested investors either through a live audio web cast at the Investor Relations section of the company's web site at www.biomedrealty.com and at www.earnings.com, which will include an online slide presentation to accompany the call, or live by calling 800-599-9795 (domestic) or 617-786-2905 (international) with call ID number 17348989. The complete webcast will be archived for 30 days on both web sites. A telephone playback of the conference call will also be available from 1:00 p.m. Pacific Time on Thursday, November 4, 2010 until midnight Pacific Time on Tuesday, November 9, 2010 by calling 888-286-8010 (domestic) or 617-801-6888 (international) and using access code 40125473.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 79 properties, representing 134 buildings with approximately 11.5 million rentable square feet. The company's properties are located predominantly in the major U.S. life
'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioSpace and BioMed Central Create Global Career Community
2. DSM Biomedical Announces Continued Partnership with Spinelab
3. BioMed Realty Trust Declares Second Quarter 2010 Common Stock and Preferred Stock Dividends
4. BioMed Realty Trust Announces Planned Filing of Resale Registration Statement in Connection With 3.75% Exchangeable Senior Notes Due 2030
5. BioMed Realty Trust Promotes Greg Lubushkin to Chief Financial Officer
6. BioMed Realty Trust Breaks Ground on 176,000 Square Foot R&D Facility for Isis Pharmaceuticals in Carlsbad, California
7. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion
8. BioMed Realty Trust to Webcast Company Presentation at Investor Day 2010
9. BioMed Realty, L.P. Prices Private Offering of $250 Million of 6.125% Senior Unsecured Notes Due 2020
10. BioMed Realty Trust Declares First Quarter 2010 Common Stock and Preferred Stock Dividends
11. Outreach Program to Increase Awareness of New Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 21, 2015 Research ... addition of the "Biomedical Refrigerators and Freezers ... Trends and Forecast 2014 - 2022" report ... biomedical refrigerators and freezers market has been segmented ... centers, blood banks, and others. The others segment ...
(Date:7/28/2015)...  Kerastem Technologies announce that the Company has received ... For Biologics Evaluation and Research (CBER) Office of Cellular, ... investigating the safety and feasibility of the Company,s technology ... baldness (androgenic alopecia). The phase II study, ... in Europe and ...
(Date:7/28/2015)... , July 28, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that it has granted to German life sciences ... development and commercialization of biotechnology (collectively, the "Optionee"), ... oral allogenic tumor vaccine technology (the "Technology"), including ... cancer which is ready to enter a Phase ...
(Date:7/27/2015)... THOUSAND OAKS, Calif. , July 27, 2015 /PRNewswire/ ... will report its second quarter financial results on Thursday, ... financial markets. The announcement will be followed by a ... PT. Participating in the call from Amgen will be ... officer, and other members of Amgen,s senior management team. ...
Breaking Biology Technology:Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Kerastem Receives Conditional Approval from FDA for Alopecia Trial 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 2Aeterna Zentaris Grants Option to Develop and Commercialize Oral Allogenic Cancer Vaccine Technology 3Amgen Announces Webcast of 2015 Second Quarter Financial Results 2
... (NASDAQ: GPRO ) today reported financial results for ... million and non-GAAP earnings per share (EPS) of $0.51.   ... products in the second quarter of 2011, while supply chain ... sales a year ago," said Carl Hull, the Company,s president ...
... DIEGO, July 28, 2011 Neurocrine Biosciences, Inc. (NASDAQ: ... June 30, 2011. For the second quarter of 2011, the Company ... to a net loss of $5.2 million, or $0.09 loss per ... ended June 30, 2011, the Company reported net income of $4.9 ...
... (NASDAQ: ITMN ) today announced that it will ... 4, 2011. A live conference call and webcast will be ... day to discuss business highlights and financial results for the ... To access the live teleconference, dial 888-567-5125 (U.S.) or 706-643-9223 ...
Cached Biology Technology:Gen-Probe Reports Financial Results for the Second Quarter of 2011 2Gen-Probe Reports Financial Results for the Second Quarter of 2011 3Gen-Probe Reports Financial Results for the Second Quarter of 2011 4Gen-Probe Reports Financial Results for the Second Quarter of 2011 5Gen-Probe Reports Financial Results for the Second Quarter of 2011 6Gen-Probe Reports Financial Results for the Second Quarter of 2011 7Gen-Probe Reports Financial Results for the Second Quarter of 2011 8Gen-Probe Reports Financial Results for the Second Quarter of 2011 9Gen-Probe Reports Financial Results for the Second Quarter of 2011 10Gen-Probe Reports Financial Results for the Second Quarter of 2011 11Gen-Probe Reports Financial Results for the Second Quarter of 2011 12Gen-Probe Reports Financial Results for the Second Quarter of 2011 13Gen-Probe Reports Financial Results for the Second Quarter of 2011 14Neurocrine Biosciences Reports Second Quarter 2011 Results 2Neurocrine Biosciences Reports Second Quarter 2011 Results 3Neurocrine Biosciences Reports Second Quarter 2011 Results 4Neurocrine Biosciences Reports Second Quarter 2011 Results 5Neurocrine Biosciences Reports Second Quarter 2011 Results 6Neurocrine Biosciences Reports Second Quarter 2011 Results 7InterMune to Release Second Quarter Financial Results on August 4 2
(Date:7/9/2015)... PLEASANTON, Calif. , July 9, 2015 /PRNewswire/ ... tools, today announcing its acquisition of Avid Nano. ... dynamic light scattering (DLS) systems.    ... world,s smallest, fastest and easiest to use protein ... system that measures a protein,s hydrodynamic size, size ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... moves through the forest boring tunnels inside the bark of trees, ... helper is a fungus that the insect plants inside the tunnels ... tiny, hitchhiking mite, which likewise carries a fungus for feeding its ... has grown even more curious. Writing in the Oct. 3 issue ...
... More than 8,000 international scientists are meeting at ... in the first-ever Joint Annual Meeting of seven ... their focus will be agricultural research. The following ... When: Oct. 5-9, 2008, Where: George R. Brown ...
... long pondered the possibility that life exists beyond Earth. ... for water, but "following the water" turns out to ... and satellites that possess liquid water is growing faster ... NASA Astrobiology Institute teams, Arizona State University researchers intend ...
Cached Biology News:Wielding microbe against microbe, beetle defends its food source 2Wielding microbe against microbe, beetle defends its food source 3Agricultural research highlighted in Houston 2NASA picks ASU research team to guide study of search for life 2NASA picks ASU research team to guide study of search for life 3
... to Cytokeratin 5 / 6 Cytokeratin ... weight, basic type of cytokeratin expressed in ... layers of stratified epithelia as well as ... cells and mesothelioma. Cytokeratin 6 (56 kD) ...
Aldolase A (N-15)...
... polyclonal NPY Y2 Receptor antiserum This ... the spinal level and is currently being characerized ... both rat and mouse and appears to work ... seen in rat. For full characterizarion in dorsal ...
Black Polypropylene 384 Round Well Plate 70/Box...
Biology Products: